Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.94

-0.3%

11:08 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4309)	7/13/2001 10:57:22 PM
From: Biomaven	Read Replies (2) of 52153

FDA Letterhead Dear [Pharma/Biotech]: (choose one) We regret to inform you that your [NDA/BLA] is not approvable for the following reason(s): - Application needs reformatting - Application needs reformatting (again!) - Subgroup analysis - Safety concerns (ask Sidney Wolfe for details) - It's already available in health food stores - Factory is dirty - We're waiting for the new Commissioner - Vaguely related to abortion (you saw what happened to the last Commissioner!) Yours Sincerely, Acting FDA Commissioner. We're doing our bit to keep America drug-free!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next